Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 study evaluating HM11260C for obesity in adults without diabetes; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HM11260C

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING